$300-500M to bring TAVR to the market???? The development cost of the product has already been done with the clinical trials currently occurring, possibly need $50M for commercialisation if AVR plan to go it alone again like what they did with ADAPT but IMO WP has learnt that to get into the surgery medical device market, the best strategy is to partner with existing company as they've already generated the market brand after many years.
- Forums
- ASX - By Stock
- AVR
- New AVR detailed research report with valuations
New AVR detailed research report with valuations, page-50
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.50 |
Change
0.070(0.61%) |
Mkt cap ! $243.1M |
Open | High | Low | Value | Volume |
$11.45 | $11.50 | $11.32 | $90.21K | 7.885K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 53 | $11.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 2061 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 53 | 11.260 |
2 | 1711 | 11.250 |
1 | 885 | 11.230 |
1 | 2000 | 11.150 |
2 | 297 | 11.000 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 2061 | 1 |
11.800 | 4634 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online